Objective: To investigate the short – and long-term dynamics in inflammation markers [systemic immune-inflammation index (SII),
 neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte (PLR), lymphocyte/ monocyte (LMR)] before after
 biological disease-modifying antirheumatic drugs (bDMARD) or targeted synthetic DMARD (tsDMARD) treatment.
 Patients Methods: wo hundred twenty-six p...